Abstract

Summary Cytoplasmic progestin receptors were assayed in the hypothalamus-preoptic area-septum and midbrain of ovariectomized guinea pigs given sequential treatment with estradiol benzoate and progesterone. As little as 50 μg of progesterone injected 40 h after estradiol benzoate caused a failure to display lordosis in response to a second progesterone injection 24 h after the first. Both 50 μg and 500 μg of progesterone decreased the concentration of cytoplasmic progestin receptors 24 h later in hypothalamus-preoptic area-septum and midbrain in estrogen-primed, ovariectomized guinea pigs. Therefore, progesterone injections that caused behavioral refractoriness to further stimulation by progesterone also decreased the concentration of availabke cytoplasmic progestin receptors. When progesterone was administered concurrently with 1.6 μg of estradiol benzoate, 500 μg, but not 100 μg suppressed behavioral responsiveness to a second progesterone injection 40 h later. The high dose, but not the low dose, also decreased the concentration of available cytoplasmic progestin receptors 40 h later in both the hypothalamus-preoptic area-septum and midbrain. These findings are consistent with the notion that a decrease in brain progestin receptor concentration is one of the subcellular mechanisms involved in failure of a second dose of progesterone to facilitate lordosis behavior in estrogen-primed animals exposed to a first dose of progesterone 24–40 h earlier.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.